1. LAPTM4B: an oncogene in various solid tumors and its functions
   Y Meng et al, 2016, Oncogene CrossRef
2. The Transcription Factor AP4 Promotes Oncogenic Phenotypes and Cisplatin Resistance by Regulating LAPTM4B Expression
   Lu Wang et al, 2018, Molecular Cancer Research CrossRef
3. LAPTM4B gene polymorphism augments the risk of cancer: Evidence from an updated meta‐analysis
   Mohammad Hashemi et al, 2018, Journal of Cellular and Molecular Medicine CrossRef
4. Association between LAPTM4B gene polymorphism and susceptibility to and prognosis of diffuse large B‑cell lymphoma
   Huirong Ding et al, 2017, Oncology Letters CrossRef
5. The relationship between LAPTM4B polymorphisms and cancer risk in Chinese Han population: a meta-analysis
   Ling-Zi Xia et al, 2015, SpringerPlus CrossRef
6. LAPTM4B is associated with poor prognosis in NSCLC and promotes the NRF2-mediated stress response pathway in lung cancer cells
   Yuho Maki et al, 2015, Scientific Reports CrossRef
7. Relationship between LAPTM4B Gene Polymorphism and Prognosis of Patients following Tumor Resection for Colorectal and Esophageal Cancers
   Xiaojing Cheng et al, 2016, PLOS ONE CrossRef
8. AP4 positively regulates LAPTM4B to promote hepatocellular carcinoma growth and metastasis, while reducing chemotherapy sensitivity
   Yue Meng et al, 2018, Molecular Oncology CrossRef
9. Role and mechanism of action of LAPTM4B in EGFR‑mediated autophagy (Review)
   Xiaokun Ji et al, 2022, Oncology Letters CrossRef
10. Serum LAPTM4B as a Potential Diagnostic and Prognostic Biomarker for Breast Cancer
    Lu Wang et al, 2022, BioMed Research International CrossRef